leisure time -WSS

leisure time

author：focus 2025-08-11 07:58:39 - browse：6815

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： FDA has safety concerns on CRISPR

explore

Wikipedia

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

Cassava reveals details — and problems — with Alzheimer's study

Chinese researcher claims birth of first gene

Senate panel to vote on hospitals, PBMs, prisoner care

Yancopoulos of Regeneron works to expand Dupixent success

Steward Health Care expansion into Malta flopped

knowledge

leisure time

entertainment

Drug repurposing or repositioning? The language matters

First Opinion Podcast: How to protect health care in times of war

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Chimpanzees, like humans and whales, get menopause: Study

Medical records are filled with copy

The FDA weighs the risks of candy

In age of alternative facts, a scholarly course on calling out crap

6 surprising facts about sugar

Hollywood unions extend contract negotiations for actors

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

focus

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Senate panel to vote on hospitals, PBMs, prisoner care

Pfizer, Moderna say biotech, pharma drug development is a sprint

Telehealth options flood the market as retailers push virtual care

Yancopoulos of Regeneron works to expand Dupixent success

6 surprising facts about sugar

explore

leisure time

Wikipedia

hotspot